A federal court judge in Florida granted a motion by Tyson Foods to transfer an antitrust lawsuit to a federal court in Illinois.
The case involves Chicken Kitchen USA, a restaurant franchisor and broiler chicken buyer, which brought the case on April 21. Chicken Kitchen alleged that Tyson and its subsidiaries Tyson Chicken, Tyson Breeders and Tyson Poultry, conspired with others to fix the price of broiler chickens “…by secretly and illegally sharing information and then using that information to coordinate output and manipulate relevant price indices,” court documents state.
In response, Tyson moved to transfer the case to the US District Court for the Northern District of Illinois, which already had consolidated 12 “factually similar” cases filed in that district into three class action cases. Part of that litigation is Maplevale Farms, a food distributor. Maplevale filed an antitrust lawsuit against Tyson and 14 other poultry companies alleging that the companies conspired to “fix, raise, maintain and stabilize,” prices for broiler chickens.
Full Content: Law 360
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Federal Judge Signals Revisions Likely in DOJ Case Targeting Live Nation Monopoly
Jan 22, 2025 by
CPI
American Airlines and JetBlue Agree to $2 Million Legal Fee Settlement with U.S. States
Jan 22, 2025 by
CPI
Federal Judge Dismisses Class Action Alleging Inflated Yacht Commission Fees
Jan 22, 2025 by
CPI
Doug Gurr Appointed Interim Chairman of UK’s Competition Authority
Jan 22, 2025 by
CPI
LinkedIn Faces Lawsuit Over Alleged Misuse of Customer Data for AI Training
Jan 22, 2025 by
Amanda Adams
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan